$1,430,622,665

Department of Health and Human Services·Office of Assistant Secretary for Preparedness and Response

to SEQIRUS INC

biotechactiveONGOING · MOD OF 2009 CONTRACT

WORK BEGAN2009-01-15·LATEST ACTION2026-06-10·SOURCEUSASPENDING·SOURCE IDCONT_AWD_HHSO100200900101C_7505_-NONE-_-NONE-

Award description

TAS::75 0140::TAS CONSTRUCTION OF VACCINE MANUFACTURING FACILITY

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Latest obligation on a 2009 vaccine manufacturing facility construction project, supporting domestic pandemic response capacity.

Sub-sectors

vaccine-manufacturingpandemic-preparednessinfrastructure-investment

Why this matters

Domestic vaccine production infrastructure is critical to U.S. pandemic preparedness and reduces reliance on foreign suppliers during health emergencies.

Supply-chain signal

Investment in domestic vaccine manufacturing reduces supply-chain vulnerability to disruptions in international pharmaceutical production and distribution.

U.S.–China competition angle

Strengthens U.S. self-sufficiency in vaccine production, reducing dependence on foreign manufacturing during pandemics or geopolitical tensions.

Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-05-17. Cost: $0.002867.

Period of performance

Start

2009-01-15

End

2029-09-30

Status

activein 1188 days

Recipient

SEQIRUS INC

UEI Z6N1LJ2RD6E3

View full profile →

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier CONT_AWD_HHSO100200900101C_7505_-NONE-_-NONE-.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.